These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38293926)

  • 21. Periodic Repolarization Dynamics Identifies ICD Responders in Nonischemic Cardiomyopathy: A DANISH Substudy.
    Boas R; Sappler N; von Stülpnagel L; Klemm M; Dixen U; Thune JJ; Pehrson S; Køber L; Nielsen JC; Videbæk L; Haarbo J; Korup E; Bruun NE; Brandes A; Eiskjær H; Thøgersen AM; Philbert BT; Svendsen JH; Tfelt-Hansen J; Bauer A; Rizas KD
    Circulation; 2022 Mar; 145(10):754-764. PubMed ID: 34889650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of implantable cardioverter-defibrillators in patients with non-ischaemic systolic heart failure and concurrent coronary atherosclerosis.
    Byrne C; Ahlehoff O; Elming MB; Pedersen F; Pehrson S; Nielsen JC; Eiskjaer H; Videbaek L; Svendsen JH; Haarbo J; Thøgersen AM; Køber L; Thune JJ
    ESC Heart Fail; 2022 Apr; 9(2):1287-1293. PubMed ID: 35106935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Right Ventricular Free Wall Strain and Effect of Defibrillator Implantation in Patients With Nonischemic Systolic Heart Failure.
    Elming MB; Jensen DH; Winsløw UC; Risum N; Butt JH; Yafasova A; Haarbo J; Philbert BT; Svendsen JH; Pehrson S; Køber L; Thune JJ
    J Card Fail; 2023 Jun; 29(6):883-892. PubMed ID: 36708755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do Implantable Cardioverter Defibrillators Reduce Mortality in Patients With Chronic Kidney Disease at All Stages?
    Fu L; Zhou Q; Zhu W; Lin H; Ding Y; Shen Y; Hu J; Hong K
    Int Heart J; 2017 May; 58(3):371-377. PubMed ID: 28539571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kidney dysfunction and deterioration of ejection fraction pose independent risk factors for mortality in implantable cardioverter-defibrillator recipients for primary prevention.
    Kreuz J; Horlbeck F; Schrickel J; Linhart M; Fimmers R; Mellert F; Nickenig G; Schwab JO
    Clin Cardiol; 2012 Sep; 35(9):575-9. PubMed ID: 22707222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial fibrosis and the effect of primary prophylactic defibrillator implantation in patients with non-ischemic systolic heart failure-DANISH-MRI.
    Elming MB; Hammer-Hansen S; Voges I; Nyktari E; Raja AA; Svendsen JH; Pehrson S; Signorovitch J; Køber L; Prasad SK; Thune JJ
    Am Heart J; 2020 Mar; 221():165-176. PubMed ID: 31955812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients.
    Jukema JW; Timal RJ; Rotmans JI; Hensen LCR; Buiten MS; de Bie MK; Putter H; Zwinderman AH; van Erven L; Krol-van Straaten MJ; Hommes N; Gabreëls B; van Dorp W; van Dam B; Herzog CA; Schalij MJ; Rabelink TJ;
    Circulation; 2019 Jun; 139(23):2628-2638. PubMed ID: 30882234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do implantable cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies.
    Makki N; Swaminathan PD; Hanmer J; Olshansky B
    Europace; 2014 Jan; 16(1):55-62. PubMed ID: 24058182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale, design, and baseline characteristics of the DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillators in patients with non-ischemic Systolic Heart failure on mortality (DANISH).
    Thune JJ; Pehrson S; Nielsen JC; Haarbo J; Videbæk L; Korup E; Jensen G; Hildebrandt P; Steffensen FH; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Egstrup K; Hastrup-Svendsen J; Høfsten DE; Torp-Pedersen C; Køber L
    Am Heart J; 2016 Sep; 179():136-41. PubMed ID: 27595688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy.
    El Moheb M; Nicolas J; Khamis AM; Iskandarani G; Akl EA; Refaat M
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012738. PubMed ID: 30537022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Outcomes in Patients with Severe Renal Dysfunction Including Dialysis Following Defibrillator Implantation.
    Bogdan S; Nof E; Eisen A; Sela R; Rosenheck S; Freedberg N; Geist M; Ben-Zvi S; Haim M; Glikson M; Goldenberg I; Suleiman M;
    Am J Nephrol; 2015; 42(4):295-304. PubMed ID: 26529418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction.
    Rørth R; Dewan P; Kristensen SL; Jhund PS; Petrie MC; Køber L; McMurray JJV
    Clin Res Cardiol; 2019 Aug; 108(8):868-877. PubMed ID: 30689020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.
    Packer DL; Prutkin JM; Hellkamp AS; Mitchell LB; Bernstein RC; Wood F; Boehmer JP; Carlson MD; Frantz RP; McNulty SE; Rogers JG; Anderson J; Johnson GW; Walsh MN; Poole JE; Mark DB; Lee KL; Bardy GH
    Circulation; 2009 Dec; 120(22):2170-6. PubMed ID: 19917887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes and Implantable Cardioverter Defibrillator in Nonischemic Systolic Heart Failure: An Extended Follow-Up Analysis of DANISH.
    Doi SN; Thune JJ; Nielsen JC; Haarbo J; Videbæk L; Rørth R; Kristensen SL; Bruun NE; Gustafsson F; Eiskjær H; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Køber L; Butt JH
    Circ Heart Fail; 2023 Oct; 16(10):e010606. PubMed ID: 37753706
    [No Abstract]   [Full Text] [Related]  

  • 35. Disparity Between Indications for and Utilization of Implantable Cardioverter Defibrillators in Asian Patients With Heart Failure.
    Chia YMF; Teng TK; Tan ESJ; Tay WT; Richards AM; Chin CWL; Shimizu W; Park SW; Hung CL; Ling LH; Ngarmukos T; Omar R; Siswanto BB; Narasimhan C; Reyes EB; Yu CM; Anand I; MacDonald MR; Yap J; Zhang S; Finkelstein EA; Lam CSP
    Circ Cardiovasc Qual Outcomes; 2017 Nov; 10(11):. PubMed ID: 29150533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Implanted Defibrillator on Mortality in Patients With Chronic Kidney Disease.
    Al-Sadawi M; Aslam F; Tao M; Ijaz H; Alsaiqali M; Fan R; Rashba EJ
    Am J Cardiol; 2023 Feb; 188():36-40. PubMed ID: 36463780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implantable Cardioverter Defibrillator in Patients With Nonischemic Systolic Heart Failure With and Without Cardiac Resynchronization Therapy: Extended Follow-Up Study of the DANISH Trial.
    Butt JH; Yafasova A; Doi SN; Nielsen JC; Haarbo J; Eiskjær H; Brandes A; Thøgersen AM; Gustafsson F; Hassager C; Svendsen JH; Høfsten DE; Videbæk L; Torp-Pedersen C; Pehrson S; Thune JJ; Køber L
    Circulation; 2023 Oct; 148(15):1179-1181. PubMed ID: 37812653
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
    Fishbein DP; Hellkamp AS; Mark DB; Walsh MN; Poole JE; Anderson J; Johnson G; Lee KL; Bardy GH;
    J Am Coll Cardiol; 2014 Jun; 63(23):2560-2568. PubMed ID: 24727258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of mortality in patients with chronic kidney disease and an implantable defibrillator: an EPGEN substudy.
    Williams ES; Shah SH; Piccini JP; Sun AY; Koontz JI; Al-Khatib SM; Hranitzky PM
    Europace; 2011 Dec; 13(12):1717-22. PubMed ID: 21821855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial.
    Adabag S; Patton KK; Buxton AE; Rector TS; Ensrud KE; Vakil K; Levy WC; Poole JE
    JAMA Cardiol; 2017 Jul; 2(7):767-774. PubMed ID: 28724134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.